The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
The Surveillance, Epidemiology, and End Results (SEER) Program and Pathology: Toward Strengthening the Critical Relationship
Open accessAbstract
The Surveillance, Epidemiology, and End Results (SEER) program of the National Cancer Institute collects data on cancer diagnoses, treatment, and survival for approximately 30% of the United States (US) population. To reflect advances in research and oncology practice, approaches to cancer control are evolving from simply enumerating the development of cancers by organ site in populations to including monitoring of cancer occurrence by histopathologic and molecular subtype, as defined by driver mutations and other alterations. SEER is an important population-based resource for understanding the implications of pathology diagnoses across demographic groups, geographic regions, and time and provides unique insights into the practice of oncology in the US that are not attainable from other sources. It provides incidence, survival, and mortality data for histopathologic cancer subtypes, and data by molecular subtyping are expanding. The program is developing systems to capture additional biomarker data, results from special populations, and expand biospecimen banking to enable cutting-edge cancer research and oncology practice. Pathology has always been central and critical to the effectiveness of SEER, and strengthening this relationship in this modern era of cancer diagnosis could be mutually beneficial. Achieving this goal requires close interactions between pathologists and the SEER program. This review provides a brief overview of SEER, focuses on facets relevant to pathology practice and research, and highlights the opportunities and challenges for pathologists to benefit from and enhance the value of SEER data.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Early detection, diagnosis, and treatment are crucial to the survival outcomes of esophageal cancer, and the 5-year survival rate of early-stage patients can exceed 95% [6].”
From Symptom Experiences before Medical Help-Seeking and Psychosocial Responses of Patients with Esophageal Cancer: A Qualitative Study. (2023) · cites this paper as [6]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Swerdlow, S. H., Campo, E., Pileri, S. A., Harris, N. L., Stein, H., Siebert, R., Advani, R., Ghielmini, M., Salles, G. A., Zelenetz, A. D., et al. (2016) · Blood · doi:10.1182/blood-2016-01-643569 · Cited by 7,831
Gail, M. H., Brinton, L. A., Byar, D. P., Corle, D. K., Green, S. B., Schairer, C., & Mulvihill, J. J. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.24.1879 · Cited by 3,334
US Incidence of Breast Cancer Subtypes Defined by Joint Hormone Receptor and HER2 Status
Howlader, N., Altekruse, S. F., Li, C. I., Chen, V. W., Clarke, C. A., Ries, L. A. G., & Cronin, K. A. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju055 · Cited by 1,572
Self-citationLindeman, N. I., Cagle, P. T., Beasley, M. B., Chitale, D. A., Dacic, S., Giaccone, G., Jenkins, R. B., Kwiatkowski, D. J., Saldivar, J.-S., Squire, J., et al. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318290868f · Cited by 1,280
The Decrease in Breast-Cancer Incidence in 2003 in the United States
Ravdin, P. M., Cronin, K. A., Howlader, N., Berg, C. D., Chlebowski, R. T., Feuer, E. J., Edwards, B. K., & Berry, D. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmsr070105 · Cited by 981
Lindeman, N. I., Cagle, P. T., Beasley, M. B., Chitale, D. A., Đačić, S., Giaccone, G., Jenkins, R. B., Kwiatkowski, D. J., Saldivar, J., Squire, J. A., et al. (2013) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2013.03.001 · Cited by 461
Albain, K. S., Unger, J. M., Crowley, J. J., Coltman, C. A., & Hershman, D. L. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp175 · Cited by 458
Cervical Cancer Trends in the United States: A 35-Year Population-Based Analysis
Adegoke, O. O., Kulasingam, S., & Virnig, B. A. (2012) · Journal of Women s Health · doi:10.1089/jwh.2011.3385 · Cited by 353
Descriptive epidemiology of dermatofibrosarcoma protuberans in the United States, 1973 to 2002
Criscione, V. D., & Weinstock, M. A. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.09.006 · Cited by 350
Breast Cancer Risk in Relation to the Interval Between Menopause and Starting Hormone Therapy
Beral, V., REEVES, G. K., Bull, D., Green, J., & Collaborators, F. T. M. W. S. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq527 · Cited by 290
Identification of Novel Genetic Markers of Breast Cancer Survival
Guo, Q. J., Schmidt, M. K., Kraft, P. L., Canisius, S., Chen, C., Khan, S., Tyrer, J. P., Bolla, M. K., Wang, Q., Dennis, J., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv081 · Cited by 234
NCI SEER public-use data: applications and limitations in oncology research.
Yu, J. B., Gross, C. P., Wilson, L. D., & Smith, B. D. (2009) · PubMed · Cited by 234
Standardized synoptic cancer pathology reporting: A population‐based approach
Srigley, J. R., McGowan, T. S., MacLean, A., Raby, M., Ross, J., Krämer, S., & Sawka, C. A. (2009) · Journal of Surgical Oncology · doi:10.1002/jso.21282 · Cited by 201
Molecular Pathology of Pancreatic Cancer
Wood, L. D., Adsay, V. N., & Hruban, R. H. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4900-3_2 · Cited by 182
Menashe, I., Anderson, W. F., Jatoi, I., & Rosenberg, P. S. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp176 · Cited by 170
Self-citationPark, H. S.-M., Lloyd, S. A. J., Decker, R. H., Wilson, L. D., & Yu, J. B. (2012) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2012.03.007 · Cited by 156
Rositch, A. F., Nowak, R. G., & Gravitt, P. E. (2014) · Cancer · doi:10.1002/cncr.28548 · Cited by 152
Limitations and Biases of the Surveillance, Epidemiology, and End Results Database
Park, H. S.-M., Lloyd, S. A. J., Decker, R. H., Wilson, L. D., & Yu, J. B. (2012) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2012.03.011 · Cited by 134
Dinh, K. T., Mahal, B. A. V., Ziehr, D. R., Muralidhar, V., Chen, Y., Viswanathan, V. B., Nezolosky, M. D., Beard, C. J., Choueiri, T. K., Martin, N. E., et al. (2015) · The Journal of Urology · doi:10.1016/j.juro.2015.02.015 · Cited by 126
The Molecular Pathology of Pancreatic Cancer
Lemoine, N. R. (1993) · Springer eBooks · doi:10.1007/978-3-642-77437-9_63 · Cited by 124
Ajani, J. A., Komaki, R. U., Putnam, J. B., Walsh, G. L., Nesbitt, J., Pisters, P. W. T., Lynch, P. M., Vaporciyan, A. A., Smythe, R. W., Lahoti, S., et al. (2001) · Cancer · doi:10.1002/1097-0142(20010715)92:2 · Cited by 117
Field, R. W., Smith, B. J., Platz, C. E., Robinson, R. A., Neuberger, J. S., Brus, C. P., & Lynch, C. F. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh189 · Cited by 109
Jordan, S. E., Watkins, A. J., Storey, M., Allen, S. J., Brooks, C. J., Garaiová, I., Heaven, M. L., Jones, R. H., Plummer, S. F., Russell, I. T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067912 · Cited by 107
Thirunavukarasu, P., Talati, C., Munjal, S., Attwood, K. M., Edge, S. B., & Francescutti, V. A. (2015) · JAMA Surgery · doi:10.1001/jamasurg.2015.0871 · Cited by 103
Contagion of Cooperation in Static and Fluid Social Networks
Jordan, J., Rand, D. G., Samuel Arbesman, C., Fowler, J. H., & Christakis, N. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066199 · Cited by 99
Pluripotent Stem Cell miRNAs and Metastasis in Invasive Breast Cancer
Volinia, S., Nuovo, G. J., Drusco, A., Costinean, S., Abujarour, R., Desponts, C., Garofalo, M., Baffa, R., Aeqilan, R., Maharry, K. S., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju324 · Cited by 78
Gentles, A. J., Bratman, S. V., Lee, L. J., Harris, J. P., Feng, W., Nair, R. V., Shultz, D. B., Nair, V. S., Hoang, C. D., West, R. B., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv211 · Cited by 76
Dinan, M. A., Mi, X., Reed, S. D., Lyman, G. H., & Curtis, L. H. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.2722 · Cited by 60
SEER Cancer Registry Biospecimen Research: Yesterday and Tomorrow
Altekruse, S. F., Rosenfeld, G. E., Carrick, D. M., Pressman, E. J., Schully, S. D., Mechanic, L. E., Cronin, K. A., Hernandez, B. Y., Lynch, C. F., Cozen, W., et al. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0490 · Cited by 46
Self-citationChamberlain, R. S., Lau, C. S. M., & Mahendraraj, K. (2015) · Cancer Management and Research · doi:10.2147/cmar.s88561 · Cited by 45
Twist1 and Y-box-binding protein-1 are potential prognostic factors in bladder cancer
Song, Y. H., Shiota, M., Yokomizo, A., Uchiumi, T., Kiyoshima, K., Kuroiwa, K., Oda, Y., & Naito, S. (2013) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2012.11.003 · Cited by 42
Shuch, B. M., Hofmann, J. N., Merino, M. J., Nix, J. W., Vourganti, S., Linehan, W. M., Schwartz, K., Ruterbusch, J. J., Colt, J. S., Purdue, M. P., et al. (2013) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2012.08.011 · Cited by 41
Effect of Changing Breast Cancer Incidence Rates on the Calibration of the Gail Model
Schonfeld, S. J., Pee, D., Greenlee, R. T., Hartge, P. A., Lacey, J. V., Park, Y., Schatzkin, A. G., Visvanathan, K., & Pfeiffer, R. M. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.2767 · Cited by 40
Prognostic Significance and Molecular Features of Colorectal Mucinous Adenocarcinomas
Wang, M., Ping, J., Li, Y., Holmqvist, A., Adell, G., Arbman, G., Zhang, H., Zhou, Z., & Sun, X. (2015) · Medicine · doi:10.1097/md.0000000000002350 · Cited by 40
Sun, M., & Trinh, Q. (2015) · British Journal of Urology · doi:10.1111/bju.13226 · Cited by 37
Wong, S. M., Freedman, R. A., Sagara, Y., Stamell, E. F., Desantis, S. D., Barry, W. T., & Golshan, M. A. (2015) · Cancer · doi:10.1002/cncr.29687 · Cited by 35
Matsuno, R. K., Sherman, M. E., Visvanathan, K., Goodman, M. T., Hernandez, B. Y., Lynch, C. F., Ioffe, O. B., Horio, D. T., Platz, C. E., Altekruse, S. F., et al. (2013) · Cancer Causes & Control · doi:10.1007/s10552-013-0157-5 · Cited by 33
Self-citationPopulation‐based assessment of determining predictors for quality of prostate cancer surveillance
Chamie, K., Williams, S. B., Hershman, D. L., Wright, J. D., Nguyen, P. L., & Hu, J. C. (2015) · Cancer · doi:10.1002/cncr.29574 · Cited by 24
Core Components of a Comprehensive Quality Assurance Program in Anatomic Pathology
Nakhleh, R. E. (2009) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e3181bb6bf7 · Cited by 23
Pathology graduate medical education (overview from 2006-2010)
Alexander, C. B. (2011) · Human Pathology · doi:10.1016/j.humpath.2010.11.008 · Cited by 18
Rose, B. S., Jiang, W., & Punglia, R. S. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3451-y · Cited by 16
Greater absolute risk for all subtypes of breast cancer in the US than Malaysia
Horne, H. N., Devi, C. R. B., Sung, H., Tang, T. S., Rosenberg, P. S., Hewitt, S. M., Sherman, M. E., Anderson, W. F., & Yang, X. R. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3243-9 · Cited by 12
Self-citationEffect of Screening Mammography on Cancer Incidence and Mortality
Elmore, J. G., & Etzioni, R. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.3056 · Cited by 10
Hall, K. N., & Kothari, R. (1999) · Academic Emergency Medicine · doi:10.1111/j.1553-2712.1999.tb00097.x · Cited by 7
Categorization of cancer through genomic complexity could guide research and management strategies
Horlings, H. M., Flanagan, A. M., & Huntsman, D. D. (2015) · The Journal of Pathology · doi:10.1002/path.4542 · Cited by 5
Rosenberg, P. S., Menashe, I., Jatoi, I., & Anderson, W. F. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp510 · Cited by 4
Self-citation
Cited by
Sorted by citations
Zhou, Y., Yang, D., Yang, Q., Lv, X., Huang, W., Zhou, Z., Wang, Y., Zhang, Z., Yuan, T., Ding, X., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-20059-6 · Cited by 672
Ward, E., Sherman, R., Henley, S. J., Jemal, A., Siegel, D. A., Feuer, E. J., Firth, A. U., Kohler, B., Scott, S., Ma, J., et al. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djz106 · Cited by 324
Blackford, A. L., Canto, M. I., Klein, A. P., Hruban, R. H., & Goggins, M. (2020) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djaa004 · Cited by 270
Atkinson, E. G., Maihofer, A. X., Kanai, M., Martin, A. R., Karczewski, K. J., Santoro, M. L., Ulirsch, J. C., Kamatani, Y., Okada, Y., Finucane, H. K., et al. (2021) · Nature Genetics · doi:10.1038/s41588-020-00766-y · Cited by 239
Zhang, L.-X., Gao, J., Long, X., Zhang, P., Yang, X., Zhu, S., Pei, X., Qiu, B., Chen, S., Lü, F., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01586-w · Cited by 149
Metadata
- Authors
- Duggan, M. A., Anderson, W. F., Altekruse, S., Penberthy, L., & Sherman, M. E.
- Affiliations
- University of Calgary (CA)
- Division of Cancer Epidemiology and Genetics (US)
- Cancer Control and Populations Sciences
- National Cancer Institute (US)
- Corresponding author
- Duggan, Máire A.
- Venue
- American Journal of Surgical Pathology
- Published
- 2016-12
- Volume
- 40
- Issue
- 12
- Pages
- e94-e102
- ISSN
- 0147-5185 (ISSN-L)
- PMC
- PMC5106320
- OpenAlex
- W2530755795
- Cited by
- 472
- References
- 46
- Citations by year
- 2026: 28 · 2025: 49 · 2024: 72 · 2023: 60 · 2022: 73 · 2021: 62 · 2020: 78 · 2019: 42 · 2018: 6 · 2017: 1
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The American Journal of Surgical Pathology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (Z99 CA999999)
- Topics
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Oncology › Cancer Diagnosis and Treatment
- Keywords
- cancer pathology, histological subtypes, molecular subtypes, driver mutations, cancer incidence, cancer survival, cancer mortality, biomarker data, cancer control
- MeSH terms
- Humans, Medical Oncology, Neoplasms, Pathology, Clinical, Biomarkers, Tumor, United States, SEER Program, Interdisciplinary Communication, Pathology, Molecular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
